 There are currently many chronic obstructive pulmonary disease clinical trials being conducted. Some focus on testing new medications while others look at better diagnosis, management and prevention methods. Others focus on preventing and treating flare-ups that are specific incidences where symptoms intensify.
There are currently many chronic obstructive pulmonary disease clinical trials being conducted. Some focus on testing new medications while others look at better diagnosis, management and prevention methods. Others focus on preventing and treating flare-ups that are specific incidences where symptoms intensify.
Chronic obstructive pulmonary disease clinical research sometimes studies ways to slow or even reverse progress of the disease. If you have been diagnosed with chronic obstructive pulmonary disease and are interested in taking part in a clinical trial, please review the list of current trials being conducted.
(For more information on COPD, please see: COPD Signs & Symptoms and COPD Treatments)
What is COPD?
Chronic obstructive pulmonary disease (COPD) is chronic bronchitis combined with emphysema. It is a condition that causes the airways in the lungs to narrow. The main symptom is shortness of breath and the main cause is smoking. Chronic obstructive pulmonary disease is a difficult condition to reverse and the symptoms tend to get worse over time. Sufferers often cough up sputum and eventually there is damage to the tissues of the lung. The symptoms usually point to chronic obstructive pulmonary disease, but lung function tests are needed for diagnosis. Chronic obstructive pulmonary disease is also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), and chronic airflow limitation (CAL).
COPD Treatments
Chronic obstructive pulmonary disease treatments include quitting smoking, vaccines and drug therapies. Smoking is not the sole cause of obstructive pulmonary disease. Sometimes it is due occupational hazards where a person is inhaling harmful dust on a frequent basis. In these cases they can work to control and limit the amount of dust they inhale. Traditional chronic obstructive pulmonary disease treatments include several medications that help relax the airway muscles to improve breathing, things like bronchodilators and anticholinergics. Corticosteroids are sometimes used to reduce inflammation of the airways. Some patients require additional oxygen. In extreme cases surgery is performed to remove damaged sections of the lungs as treatment for chronic pulmonary disease.
					
					We've found
					890 Chronic Obstructive Pulmonary Disease				
					clinical trials				
				
			
		
							
  	
	Pulmonary / Respiratory Diseases Clinical Trial
	Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
		Status: Enrolling	
	
	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary / Respiratory Diseases Clinical Trial
	Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
		Status: Enrolling
  
							
  	
	Pulmonary / Respiratory Diseases Clinical Trial
	Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial
		Status: Enrolling	
	
	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Obstructive Pulmonary Disease Clinical Trial
	Effects of Marijuana Used on Lung Function in Persons With Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Chronic Obstructive Pulmonary Disease Clinical Trial
	Effects of Marijuana Used on Lung Function in Persons With Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 5/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Obstructive Pulmonary Disease Clinical Trial
	Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
		Status: Enrolling,
							Phase
  
							
  	
	Chronic Obstructive Pulmonary Disease Clinical Trial
	Boston Early-Onset Chronic Obstructive Pulmonary Disease (COPD) Study
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)
		Status: Enrolling	
	
	
			Updated: 10/17/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling
  
							
  	
	Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling	
	
	
			Updated: 10/29/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling
  
							
  	
	Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling	
	
	
			Updated: 10/29/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling
  
							
  	
	Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling	
	
	
			Updated: 10/29/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling
  
							
  	
	Pulmonary Emphysema Clinical Trial
	Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
		Status: Enrolling	
	
	
			Updated: 10/29/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling	
	
	
			Updated: 9/18/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling	
	
	
			Updated: 9/18/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling	
	
	
			Updated: 9/18/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling	
	
	
			Updated: 9/18/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection
		Status: Enrolling	
	
	
			Updated: 9/18/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Emphysema in Alpha-1 PI Deficiency Clinical Trial
	Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Emphysema in Alpha-1 PI Deficiency Clinical Trial
	Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Study of Use of CTC in NSCLC
		Status: Enrolling
  
							
  	
	Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Study of Use of CTC in NSCLC
		Status: Enrolling	
	
	
			Updated: 11/15/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium
		Status: Enrolling,
							Phase
  
							
  	
	Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	HIV+ Alveolar Macrophage Oxidant-mediated Apoptosis of Pulmonary Endothelium
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Advanced COPD GOLD Stage 3 or 4 With Cachexia Clinical Trial
	Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD
		Status: Enrolling
  
							
  	
	Advanced COPD GOLD Stage 3 or 4 With Cachexia Clinical Trial
	Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD
		Status: Enrolling	
	
	
			Updated: 2/18/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Click here to add this to my saved trials
  
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 COPD Clinical Trial
	PK Study of PT003 and PT001 in Japanese Healthy Subjects
		Status: Enrolling,
							Phase
													 I
  
							
  	
	COPD Clinical Trial
	PK Study of PT003 and PT001 in Japanese Healthy Subjects
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 7/18/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary / Respiratory Diseases, Orthopedics / Podiatry, Other Clinical Trial
	Electrical Impedance Imaging of Patients on Mechanical Ventilation
		Status: Enrolling
  
							
  	
	Pulmonary / Respiratory Diseases, Orthopedics / Podiatry, Other Clinical Trial
	Electrical Impedance Imaging of Patients on Mechanical Ventilation
		Status: Enrolling	
	
	
			Updated: 7/25/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Obstructive Pulmonary Disease Clinical Trial
	The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Chronic Obstructive Pulmonary Disease Clinical Trial
	The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 5/1/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Obstructive Pulmonary Disease Clinical Trial
	Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Chronic Obstructive Pulmonary Disease Clinical Trial
	Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 2/26/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Obstructive Pulmonary Disease Clinical Trial
	Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Chronic Obstructive Pulmonary Disease Clinical Trial
	Safety and Efficacy of Adipose Derived Stem Cells for Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 2/26/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Obstructive Pulmonary Disease Clinical Trial
	A Phase 2a Study to Assess Safety, Daily Symptoms, Pharmacokinetics (PK), and Biomarkers of YPL-001 in Chronic Obstructive Pulmonary Disease (COPD) Patients
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Chronic Obstructive Pulmonary Disease Clinical Trial
	A Phase 2a Study to Assess Safety, Daily Symptoms, Pharmacokinetics (PK), and Biomarkers of YPL-001 in Chronic Obstructive Pulmonary Disease (COPD) Patients
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 11/29/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary / Respiratory Diseases Clinical Trial
	Environment Effect on Six-Minute Walk Test Performance
		Status: Enrolling
  
							
  	
	Pulmonary / Respiratory Diseases Clinical Trial
	Environment Effect on Six-Minute Walk Test Performance
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neurology, Pulmonary / Respiratory Diseases Clinical Trial
	Randomized Evaluation of Default Access to Palliative Services
		Status: Enrolling
  
							
  	
	Neurology, Pulmonary / Respiratory Diseases Clinical Trial
	Randomized Evaluation of Default Access to Palliative Services
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 COPD Clinical Trial
	The Trajectory of Physical Activity Following Pulmonary Rehabilitation
		Status: Enrolling
  
							
  	
	COPD Clinical Trial
	The Trajectory of Physical Activity Following Pulmonary Rehabilitation
		Status: Enrolling	
	
	
			Updated: 1/3/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 COPD Clinical Trial
	Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD
		Status: Enrolling,
							Phase
													 III
  
							
  	
	COPD Clinical Trial
	Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 2/17/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 COPD Clinical Trial
	Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPD
		Status: Enrolling,
							Phase
													 III
  
							
  	
	COPD Clinical Trial
	Study to Evaluate the Treatment Effect of PT003 on Cardiovascular Hemodynamics in Subjects With Moderate to Severe COPD
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
	An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFE
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Obstuctive Pulmonary Disease Clinical Trial
	Lung Microbiome and Inflammation in Early COPD
		Status: Enrolling,
							Phase
  
							
  	
	Chronic Obstuctive Pulmonary Disease Clinical Trial
	Lung Microbiome and Inflammation in Early COPD
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	Hepatitis C Virus(HCV) Heart and Lung Study
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
	Hepatitis C Virus(HCV) Heart and Lung Study
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Gastroenterology, Musculoskeletal, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
	Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Gastroenterology, Musculoskeletal, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
	Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
		Status: Enrolling	
	
	
			Updated: 1/10/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Emphysema Clinical Trial
	Losartan Effects on Emphysema Progression
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Emphysema Clinical Trial
	Losartan Effects on Emphysema Progression
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Emphysema Clinical Trial
	Losartan Effects on Emphysema Progression
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Emphysema Clinical Trial
	Losartan Effects on Emphysema Progression
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Emphysema Clinical Trial
	Losartan Effects on Emphysema Progression
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Emphysema Clinical Trial
	Losartan Effects on Emphysema Progression
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary / Respiratory Diseases Clinical Trial
	The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy
		Status: Enrolling
  
							
  	
	Pulmonary / Respiratory Diseases Clinical Trial
	The Efficacy of the AIRVO Warm Humidifier as an Add on to Oxygen Therapy
		Status: Enrolling	
	
	
			Updated: 3/15/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Pulmonary Disease, Chronic Obstructive Clinical Trial
	Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
	INtervention Study In overweiGHT Patients With COPD
		Status: Enrolling
  
							
  	
	Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
	INtervention Study In overweiGHT Patients With COPD
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
	INtervention Study In overweiGHT Patients With COPD
		Status: Enrolling
  
							
  	
	Endocrinology, Pulmonary / Respiratory Diseases Clinical Trial
	INtervention Study In overweiGHT Patients With COPD
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
 
   
  Updated: 5/12/2016
 
  Updated: 12/31/1969
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/17/2012
 
  Updated: 10/29/2013
 
  Updated: 10/29/2013
 
  Updated: 10/29/2013
 
  Updated: 10/29/2013
 
  Updated: 9/18/2012
 
  Updated: 9/18/2012
 
  Updated: 9/18/2012
 
  Updated: 9/18/2012
 
  Updated: 9/18/2012
 
  Updated: 12/31/1969
 
  Updated: 11/15/2013
 
  Updated: 12/31/1969
 
  Updated: 2/18/2014
 
   
  Updated: 7/18/2014
 
  Updated: 7/25/2016
 
  Updated: 5/1/2018
 
  Updated: 2/26/2016
 
  Updated: 2/26/2016
 
  Updated: 11/29/2016
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 1/3/2017
 
  Updated: 2/17/2016
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 1/10/2018
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 3/15/2017
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  